Edvince
About:
Edvince is a biotechnology company that develops a new treatment.
Website: http://www.edvince.com/
Top Investors: European Innovation Council, Almi Invest
Description:
Edvince is a biotechnology company that develops a new treatment that has great potential to minimize brain damage in a stroke. The treatment is based on Professor Lars Edvinsson's long-term research.
Total Funding Amount:
2.5M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Lund, Skane Lan, Sweden
Founded Date:
2003-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2021-10-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai